nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—bile duct—pancreatic cancer	0.24	0.771	CbGeAlD
Amifostine—ALPPL2—gall bladder—pancreatic cancer	0.0511	0.164	CbGeAlD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—JAG2—pancreatic cancer	0.0392	0.126	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—JAG1—pancreatic cancer	0.0313	0.101	CbGpPWpGaD
Amifostine—ALPPL2—digestive system—pancreatic cancer	0.0201	0.0647	CbGeAlD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—NOTCH1—pancreatic cancer	0.0173	0.0558	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatic cancer	0.0155	0.05	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—PTCH1—pancreatic cancer	0.0121	0.039	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—PTHLH—pancreatic cancer	0.0121	0.039	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PTCH1—pancreatic cancer	0.0103	0.0332	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PTHLH—pancreatic cancer	0.0103	0.0332	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—pancreatic cancer	0.0101	0.0326	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—PLAU—pancreatic cancer	0.00658	0.0212	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—HIF1A—pancreatic cancer	0.00648	0.0209	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—NFKBIA—pancreatic cancer	0.0059	0.019	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PLAU—pancreatic cancer	0.00559	0.018	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CNR1—pancreatic cancer	0.00534	0.0172	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP2—pancreatic cancer	0.00506	0.0163	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP3—pancreatic cancer	0.00403	0.013	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—MMP9—pancreatic cancer	0.0039	0.0126	CbGpPWpGaD
Amifostine—Hypocalcaemia—Gemcitabine—pancreatic cancer	0.00386	0.0102	CcSEcCtD
Amifostine—Supraventricular tachycardia—Docetaxel—pancreatic cancer	0.00383	0.0101	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—pancreatic cancer	0.0038	0.0123	CbGpPWpGaD
Amifostine—Hiccups—Irinotecan—pancreatic cancer	0.00363	0.00957	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—SRC—pancreatic cancer	0.00351	0.0113	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—pancreatic cancer	0.0035	0.0113	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—TSC2—pancreatic cancer	0.00346	0.0112	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—STAT3—pancreatic cancer	0.00338	0.0109	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.00333	0.00877	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—MMP9—pancreatic cancer	0.00332	0.0107	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—TGFB1—pancreatic cancer	0.00321	0.0104	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—NFKBIA—pancreatic cancer	0.00316	0.0102	CbGpPWpGaD
Amifostine—Myocardial ischaemia—Docetaxel—pancreatic cancer	0.00312	0.00823	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—EGFR—pancreatic cancer	0.00307	0.00992	CbGpPWpGaD
Amifostine—Rigors—Docetaxel—pancreatic cancer	0.00307	0.0081	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—pancreatic cancer	0.00298	0.0096	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—pancreatic cancer	0.00296	0.00954	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.00288	0.0076	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00285	0.00752	CcSEcCtD
Amifostine—Acute coronary syndrome—Tamoxifen—pancreatic cancer	0.00284	0.00748	CcSEcCtD
Amifostine—Chest discomfort—Docetaxel—pancreatic cancer	0.00284	0.00748	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00282	0.00744	CcSEcCtD
Amifostine—Myocardial infarction—Tamoxifen—pancreatic cancer	0.00282	0.00744	CcSEcCtD
Amifostine—Acute coronary syndrome—Erlotinib—pancreatic cancer	0.00281	0.0074	CcSEcCtD
Amifostine—Renal failure—Erlotinib—pancreatic cancer	0.0028	0.00738	CcSEcCtD
Amifostine—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.00279	0.00736	CcSEcCtD
Amifostine—Myocardial infarction—Erlotinib—pancreatic cancer	0.00279	0.00736	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—TGFB1—pancreatic cancer	0.00273	0.00881	CbGpPWpGaD
Amifostine—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.00272	0.00718	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—TSC2—pancreatic cancer	0.00271	0.00873	CbGpPWpGaD
Amifostine—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.00265	0.00699	CcSEcCtD
Amifostine—Cardiac arrest—Irinotecan—pancreatic cancer	0.0025	0.00661	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00244	0.00644	CcSEcCtD
Amifostine—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00244	0.00644	CcSEcCtD
Amifostine—Acute coronary syndrome—Sunitinib—pancreatic cancer	0.00243	0.00641	CcSEcCtD
Amifostine—Renal failure—Sunitinib—pancreatic cancer	0.00242	0.00639	CcSEcCtD
Amifostine—Erythema multiforme—Erlotinib—pancreatic cancer	0.00242	0.00637	CcSEcCtD
Amifostine—Cardiac arrest—Fluorouracil—pancreatic cancer	0.0024	0.00633	CcSEcCtD
Amifostine—Flushing—Tamoxifen—pancreatic cancer	0.0024	0.00632	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CG—pancreatic cancer	0.00239	0.00771	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00231	0.00609	CcSEcCtD
Amifostine—Arrhythmia—Tamoxifen—pancreatic cancer	0.00231	0.00609	CcSEcCtD
Amifostine—Chills—Erlotinib—pancreatic cancer	0.00229	0.00605	CcSEcCtD
Amifostine—Arrhythmia—Erlotinib—pancreatic cancer	0.00228	0.00602	CcSEcCtD
Amifostine—Bradycardia—Sunitinib—pancreatic cancer	0.00225	0.00594	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—AKT1—pancreatic cancer	0.00223	0.00721	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—pancreatic cancer	0.00218	0.00703	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CASP3—pancreatic cancer	0.00216	0.00696	CbGpPWpGaD
Amifostine—Feeling hot—Epirubicin—pancreatic cancer	0.00216	0.00569	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CD—pancreatic cancer	0.0021	0.00678	CbGpPWpGaD
Amifostine—Erythema multiforme—Sunitinib—pancreatic cancer	0.00209	0.00552	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—CTNNB1—pancreatic cancer	0.00208	0.00671	CbGpPWpGaD
Amifostine—Rigors—Epirubicin—pancreatic cancer	0.00207	0.00547	CcSEcCtD
Amifostine—Flushing—Sunitinib—pancreatic cancer	0.00205	0.00542	CcSEcCtD
Amifostine—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.002	0.00528	CcSEcCtD
Amifostine—Renal failure—Irinotecan—pancreatic cancer	0.002	0.00526	CcSEcCtD
Amifostine—Syncope—Erlotinib—pancreatic cancer	0.002	0.00526	CcSEcCtD
Amifostine—Feeling hot—Doxorubicin—pancreatic cancer	0.00199	0.00526	CcSEcCtD
Amifostine—Myocardial infarction—Irinotecan—pancreatic cancer	0.00199	0.00525	CcSEcCtD
Amifostine—Chills—Sunitinib—pancreatic cancer	0.00199	0.00524	CcSEcCtD
Amifostine—Arrhythmia—Sunitinib—pancreatic cancer	0.00198	0.00521	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00196	0.00517	CcSEcCtD
Amifostine—Loss of consciousness—Erlotinib—pancreatic cancer	0.00196	0.00516	CcSEcCtD
Amifostine—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.00195	0.00514	CcSEcCtD
Amifostine—Renal failure—Gemcitabine—pancreatic cancer	0.00194	0.00513	CcSEcCtD
Amifostine—Hypertension—Tamoxifen—pancreatic cancer	0.00194	0.00512	CcSEcCtD
Amifostine—Myocardial infarction—Gemcitabine—pancreatic cancer	0.00194	0.00511	CcSEcCtD
Amifostine—Atrial fibrillation—Docetaxel—pancreatic cancer	0.00192	0.00507	CcSEcCtD
Amifostine—Rigors—Doxorubicin—pancreatic cancer	0.00192	0.00506	CcSEcCtD
Amifostine—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.00192	0.00506	CcSEcCtD
Amifostine—Chest pain—Tamoxifen—pancreatic cancer	0.00191	0.00505	CcSEcCtD
Amifostine—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00191	0.00503	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—AKT1—pancreatic cancer	0.0019	0.00613	CbGpPWpGaD
Amifostine—Chest pain—Erlotinib—pancreatic cancer	0.00189	0.005	CcSEcCtD
Amifostine—Discomfort—Tamoxifen—pancreatic cancer	0.00189	0.00499	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—SRC—pancreatic cancer	0.00188	0.00606	CbGpPWpGaD
Amifostine—Bradycardia—Irinotecan—pancreatic cancer	0.00186	0.00489	CcSEcCtD
Amifostine—Hypocalcaemia—Epirubicin—pancreatic cancer	0.00185	0.00488	CcSEcCtD
Amifostine—ENPP1—Disease—PRSS1—pancreatic cancer	0.00183	0.00591	CbGpPWpGaD
Amifostine—ENPP1—Disease—ZNRF3—pancreatic cancer	0.00183	0.00591	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CB—pancreatic cancer	0.00183	0.00591	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—STAT3—pancreatic cancer	0.00181	0.00584	CbGpPWpGaD
Amifostine—Shock—Erlotinib—pancreatic cancer	0.00179	0.00471	CcSEcCtD
Amifostine—Hypocalcaemia—Doxorubicin—pancreatic cancer	0.00171	0.00451	CcSEcCtD
Amifostine—Hiccups—Epirubicin—pancreatic cancer	0.00169	0.00446	CcSEcCtD
Amifostine—Flushing—Irinotecan—pancreatic cancer	0.00169	0.00446	CcSEcCtD
Amifostine—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00168	0.00443	CcSEcCtD
Amifostine—Convulsion—Sunitinib—pancreatic cancer	0.00167	0.0044	CcSEcCtD
Amifostine—Hypertension—Sunitinib—pancreatic cancer	0.00166	0.00439	CcSEcCtD
Amifostine—ENPP1—Disease—DTX1—pancreatic cancer	0.00166	0.00535	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00164	0.00433	CcSEcCtD
Amifostine—Chest pain—Sunitinib—pancreatic cancer	0.00164	0.00432	CcSEcCtD
Amifostine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00164	0.00432	CcSEcCtD
Amifostine—Chills—Irinotecan—pancreatic cancer	0.00164	0.00431	CcSEcCtD
Amifostine—Arrhythmia—Irinotecan—pancreatic cancer	0.00163	0.00429	CcSEcCtD
Amifostine—Dyspnoea—Erlotinib—pancreatic cancer	0.00162	0.00427	CcSEcCtD
Amifostine—Chills—Gemcitabine—pancreatic cancer	0.00159	0.0042	CcSEcCtD
Amifostine—Arrhythmia—Gemcitabine—pancreatic cancer	0.00159	0.00418	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PTEN—pancreatic cancer	0.00158	0.00511	CbGpPWpGaD
Amifostine—Hiccups—Doxorubicin—pancreatic cancer	0.00157	0.00413	CcSEcCtD
Amifostine—Arrhythmia—Fluorouracil—pancreatic cancer	0.00156	0.00411	CcSEcCtD
Amifostine—Shock—Sunitinib—pancreatic cancer	0.00155	0.00408	CcSEcCtD
Amifostine—ENPP1—Metabolism—PRSS1—pancreatic cancer	0.00154	0.00495	CbGpPWpGaD
Amifostine—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00147	0.00388	CcSEcCtD
Amifostine—Urticaria—Tamoxifen—pancreatic cancer	0.00146	0.00385	CcSEcCtD
Amifostine—Body temperature increased—Erlotinib—pancreatic cancer	0.00144	0.00379	CcSEcCtD
Amifostine—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00143	0.00378	CcSEcCtD
Amifostine—Malaise—Irinotecan—pancreatic cancer	0.00143	0.00377	CcSEcCtD
Amifostine—Syncope—Irinotecan—pancreatic cancer	0.00142	0.00375	CcSEcCtD
Amifostine—Dyspnoea—Sunitinib—pancreatic cancer	0.0014	0.0037	CcSEcCtD
Amifostine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00139	0.00368	CcSEcCtD
Amifostine—Malaise—Gemcitabine—pancreatic cancer	0.00139	0.00368	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00139	0.00367	CcSEcCtD
Amifostine—ENPP1—Disease—DTX4—pancreatic cancer	0.00139	0.00448	CbGpPWpGaD
Amifostine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00138	0.00365	CcSEcCtD
Amifostine—Renal failure—Docetaxel—pancreatic cancer	0.00138	0.00364	CcSEcCtD
Amifostine—Myocardial infarction—Docetaxel—pancreatic cancer	0.00138	0.00363	CcSEcCtD
Amifostine—Hypertension—Irinotecan—pancreatic cancer	0.00137	0.00361	CcSEcCtD
Amifostine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00135	0.00357	CcSEcCtD
Amifostine—ENPP1—Disease—PPP2R5B—pancreatic cancer	0.00135	0.00436	CbGpPWpGaD
Amifostine—Discomfort—Irinotecan—pancreatic cancer	0.00133	0.00352	CcSEcCtD
Amifostine—Hypertension—Gemcitabine—pancreatic cancer	0.00133	0.00352	CcSEcCtD
Amifostine—ENPP1—Metabolism—ARG2—pancreatic cancer	0.00133	0.00429	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—HRAS—pancreatic cancer	0.00132	0.00427	CbGpPWpGaD
Amifostine—Convulsion—Fluorouracil—pancreatic cancer	0.00132	0.00347	CcSEcCtD
Amifostine—Chest pain—Gemcitabine—pancreatic cancer	0.00132	0.00347	CcSEcCtD
Amifostine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.0013	0.00343	CcSEcCtD
Amifostine—ENPP1—Disease—HEY2—pancreatic cancer	0.0013	0.0042	CbGpPWpGaD
Amifostine—Discomfort—Gemcitabine—pancreatic cancer	0.0013	0.00343	CcSEcCtD
Amifostine—Pruritus—Tamoxifen—pancreatic cancer	0.0013	0.00342	CcSEcCtD
Amifostine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00129	0.00341	CcSEcCtD
Amifostine—Chest pain—Fluorouracil—pancreatic cancer	0.00129	0.00341	CcSEcCtD
Amifostine—Pruritus—Erlotinib—pancreatic cancer	0.00128	0.00339	CcSEcCtD
Amifostine—Discomfort—Fluorouracil—pancreatic cancer	0.00128	0.00337	CcSEcCtD
Amifostine—Shock—Irinotecan—pancreatic cancer	0.00127	0.00336	CcSEcCtD
Amifostine—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00127	0.00335	CcSEcCtD
Amifostine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00126	0.00333	CcSEcCtD
Amifostine—Body temperature increased—Sunitinib—pancreatic cancer	0.00124	0.00328	CcSEcCtD
Amifostine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00124	0.00327	CcSEcCtD
Amifostine—Dizziness—Tamoxifen—pancreatic cancer	0.00121	0.0032	CcSEcCtD
Amifostine—Tachycardia—Fluorouracil—pancreatic cancer	0.00121	0.00319	CcSEcCtD
Amifostine—Hypotension—Irinotecan—pancreatic cancer	0.00121	0.00319	CcSEcCtD
Amifostine—ENPP1—Disease—HEY1—pancreatic cancer	0.0012	0.00389	CbGpPWpGaD
Amifostine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.0012	0.00318	CcSEcCtD
Amifostine—Dizziness—Erlotinib—pancreatic cancer	0.0012	0.00317	CcSEcCtD
Amifostine—Erythema multiforme—Docetaxel—pancreatic cancer	0.00119	0.00314	CcSEcCtD
Amifostine—Hypotension—Gemcitabine—pancreatic cancer	0.00118	0.00311	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00117	0.0031	CcSEcCtD
Amifostine—Flushing—Docetaxel—pancreatic cancer	0.00117	0.00308	CcSEcCtD
Amifostine—Cardiac arrest—Epirubicin—pancreatic cancer	0.00117	0.00308	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—AKT1—pancreatic cancer	0.00117	0.00377	CbGpPWpGaD
Amifostine—Vomiting—Tamoxifen—pancreatic cancer	0.00117	0.00308	CcSEcCtD
Amifostine—ENPP1—Metabolism—TYMP—pancreatic cancer	0.00116	0.00375	CbGpPWpGaD
Amifostine—Hypotension—Fluorouracil—pancreatic cancer	0.00116	0.00306	CcSEcCtD
Amifostine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00116	0.00305	CcSEcCtD
Amifostine—Rash—Tamoxifen—pancreatic cancer	0.00116	0.00305	CcSEcCtD
Amifostine—Dermatitis—Tamoxifen—pancreatic cancer	0.00116	0.00305	CcSEcCtD
Amifostine—Vomiting—Erlotinib—pancreatic cancer	0.00115	0.00304	CcSEcCtD
Amifostine—Dyspnoea—Irinotecan—pancreatic cancer	0.00115	0.00304	CcSEcCtD
Amifostine—Somnolence—Irinotecan—pancreatic cancer	0.00115	0.00304	CcSEcCtD
Amifostine—Rash—Erlotinib—pancreatic cancer	0.00114	0.00302	CcSEcCtD
Amifostine—Dermatitis—Erlotinib—pancreatic cancer	0.00114	0.00302	CcSEcCtD
Amifostine—Chills—Docetaxel—pancreatic cancer	0.00113	0.00298	CcSEcCtD
Amifostine—Arrhythmia—Docetaxel—pancreatic cancer	0.00113	0.00297	CcSEcCtD
Amifostine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00112	0.00297	CcSEcCtD
Amifostine—Somnolence—Gemcitabine—pancreatic cancer	0.00112	0.00296	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CA—pancreatic cancer	0.00112	0.0036	CbGpPWpGaD
Amifostine—Pruritus—Sunitinib—pancreatic cancer	0.00111	0.00293	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00111	0.00292	CcSEcCtD
Amifostine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00111	0.00292	CcSEcCtD
Amifostine—Somnolence—Fluorouracil—pancreatic cancer	0.0011	0.00291	CcSEcCtD
Amifostine—Nausea—Tamoxifen—pancreatic cancer	0.00109	0.00288	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00108	0.00285	CcSEcCtD
Amifostine—Nausea—Erlotinib—pancreatic cancer	0.00108	0.00284	CcSEcCtD
Amifostine—ENPP1—Disease—JAG2—pancreatic cancer	0.00107	0.00345	CbGpPWpGaD
Amifostine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00107	0.00281	CcSEcCtD
Amifostine—ENPP1—Disease—MEN1—pancreatic cancer	0.00105	0.0034	CbGpPWpGaD
Amifostine—ENPP1—Disease—SLC2A2—pancreatic cancer	0.00105	0.00337	CbGpPWpGaD
Amifostine—Dizziness—Sunitinib—pancreatic cancer	0.00104	0.00274	CcSEcCtD
Amifostine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00104	0.00274	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—HRAS—pancreatic cancer	0.00103	0.00333	CbGpPWpGaD
Amifostine—Body temperature increased—Irinotecan—pancreatic cancer	0.00102	0.0027	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00102	0.0027	CcSEcCtD
Amifostine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00102	0.0027	CcSEcCtD
Amifostine—ENPP1—Disease—SHH—pancreatic cancer	0.001	0.00324	CbGpPWpGaD
Amifostine—Vomiting—Sunitinib—pancreatic cancer	0.000999	0.00264	CcSEcCtD
Amifostine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000997	0.00263	CcSEcCtD
Amifostine—ENPP1—Disease—IAPP—pancreatic cancer	0.000992	0.0032	CbGpPWpGaD
Amifostine—Rash—Sunitinib—pancreatic cancer	0.000991	0.00261	CcSEcCtD
Amifostine—Dermatitis—Sunitinib—pancreatic cancer	0.00099	0.00261	CcSEcCtD
Amifostine—Urticaria—Fluorouracil—pancreatic cancer	0.000985	0.0026	CcSEcCtD
Amifostine—Syncope—Docetaxel—pancreatic cancer	0.000983	0.00259	CcSEcCtD
Amifostine—Body temperature increased—Fluorouracil—pancreatic cancer	0.00098	0.00259	CcSEcCtD
Amifostine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000964	0.00254	CcSEcCtD
Amifostine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000954	0.00252	CcSEcCtD
Amifostine—ENPP1—Disease—HSPA1B—pancreatic cancer	0.000952	0.00307	CbGpPWpGaD
Amifostine—Convulsion—Docetaxel—pancreatic cancer	0.00095	0.00251	CcSEcCtD
Amifostine—Hypertension—Docetaxel—pancreatic cancer	0.000947	0.0025	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000938	0.00248	CcSEcCtD
Amifostine—ENPP1—Metabolism—GLP1R—pancreatic cancer	0.000938	0.00303	CbGpPWpGaD
Amifostine—Chest pain—Docetaxel—pancreatic cancer	0.000934	0.00246	CcSEcCtD
Amifostine—Nausea—Sunitinib—pancreatic cancer	0.000934	0.00246	CcSEcCtD
Amifostine—Renal failure—Epirubicin—pancreatic cancer	0.00093	0.00245	CcSEcCtD
Amifostine—ENPP1—Metabolism—DPYD—pancreatic cancer	0.000923	0.00298	CbGpPWpGaD
Amifostine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000914	0.00241	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—AKT1—pancreatic cancer	0.000913	0.00294	CbGpPWpGaD
Amifostine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000895	0.00236	CcSEcCtD
Amifostine—Pruritus—Gemcitabine—pancreatic cancer	0.000892	0.00235	CcSEcCtD
Amifostine—Shock—Docetaxel—pancreatic cancer	0.000881	0.00232	CcSEcCtD
Amifostine—Pruritus—Fluorouracil—pancreatic cancer	0.000877	0.00231	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC2A2—pancreatic cancer	0.000876	0.00283	CbGpPWpGaD
Amifostine—Tachycardia—Docetaxel—pancreatic cancer	0.000873	0.0023	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000868	0.00229	CcSEcCtD
Amifostine—Bradycardia—Epirubicin—pancreatic cancer	0.000865	0.00228	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—pancreatic cancer	0.000861	0.00227	CcSEcCtD
Amifostine—Dizziness—Irinotecan—pancreatic cancer	0.000856	0.00226	CcSEcCtD
Amifostine—ENPP1—Disease—JAG1—pancreatic cancer	0.000852	0.00275	CbGpPWpGaD
Amifostine—Hypotension—Docetaxel—pancreatic cancer	0.000836	0.00221	CcSEcCtD
Amifostine—Vomiting—Irinotecan—pancreatic cancer	0.000823	0.00217	CcSEcCtD
Amifostine—Dizziness—Fluorouracil—pancreatic cancer	0.00082	0.00216	CcSEcCtD
Amifostine—Rash—Irinotecan—pancreatic cancer	0.000816	0.00215	CcSEcCtD
Amifostine—Dermatitis—Irinotecan—pancreatic cancer	0.000816	0.00215	CcSEcCtD
Amifostine—ENPP1—Disease—CD44—pancreatic cancer	0.00081	0.00261	CbGpPWpGaD
Amifostine—ENPP1—Disease—HSPA1A—pancreatic cancer	0.000804	0.00259	CbGpPWpGaD
Amifostine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000803	0.00212	CcSEcCtD
Amifostine—Vomiting—Gemcitabine—pancreatic cancer	0.000802	0.00212	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—pancreatic cancer	0.0008	0.00211	CcSEcCtD
Amifostine—Dyspnoea—Docetaxel—pancreatic cancer	0.000798	0.0021	CcSEcCtD
Amifostine—Somnolence—Docetaxel—pancreatic cancer	0.000796	0.0021	CcSEcCtD
Amifostine—Rash—Gemcitabine—pancreatic cancer	0.000795	0.0021	CcSEcCtD
Amifostine—Dermatitis—Gemcitabine—pancreatic cancer	0.000794	0.0021	CcSEcCtD
Amifostine—Flushing—Epirubicin—pancreatic cancer	0.000789	0.00208	CcSEcCtD
Amifostine—Vomiting—Fluorouracil—pancreatic cancer	0.000788	0.00208	CcSEcCtD
Amifostine—Rash—Fluorouracil—pancreatic cancer	0.000782	0.00206	CcSEcCtD
Amifostine—Dermatitis—Fluorouracil—pancreatic cancer	0.000781	0.00206	CcSEcCtD
Amifostine—Nausea—Irinotecan—pancreatic cancer	0.000769	0.00203	CcSEcCtD
Amifostine—Chills—Epirubicin—pancreatic cancer	0.000762	0.00201	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—pancreatic cancer	0.000759	0.002	CcSEcCtD
Amifostine—Nausea—Gemcitabine—pancreatic cancer	0.000749	0.00198	CcSEcCtD
Amifostine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000743	0.00196	CcSEcCtD
Amifostine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000738	0.00195	CcSEcCtD
Amifostine—Nausea—Fluorouracil—pancreatic cancer	0.000737	0.00194	CcSEcCtD
Amifostine—Flushing—Doxorubicin—pancreatic cancer	0.00073	0.00192	CcSEcCtD
Amifostine—Body temperature increased—Docetaxel—pancreatic cancer	0.000708	0.00187	CcSEcCtD
Amifostine—Chills—Doxorubicin—pancreatic cancer	0.000705	0.00186	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000702	0.00185	CcSEcCtD
Amifostine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000686	0.00181	CcSEcCtD
Amifostine—ENPP1—Metabolism—CD44—pancreatic cancer	0.000678	0.00219	CbGpPWpGaD
Amifostine—Malaise—Epirubicin—pancreatic cancer	0.000667	0.00176	CcSEcCtD
Amifostine—Syncope—Epirubicin—pancreatic cancer	0.000663	0.00175	CcSEcCtD
Amifostine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000659	0.00174	CcSEcCtD
Amifostine—ENPP1—Metabolism—GCG—pancreatic cancer	0.00065	0.0021	CbGpPWpGaD
Amifostine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00065	0.00171	CcSEcCtD
Amifostine—Convulsion—Epirubicin—pancreatic cancer	0.000641	0.00169	CcSEcCtD
Amifostine—ENPP1—Disease—SMAD4—pancreatic cancer	0.000639	0.00206	CbGpPWpGaD
Amifostine—Hypertension—Epirubicin—pancreatic cancer	0.000639	0.00168	CcSEcCtD
Amifostine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000635	0.00167	CcSEcCtD
Amifostine—Pruritus—Docetaxel—pancreatic cancer	0.000633	0.00167	CcSEcCtD
Amifostine—Chest pain—Epirubicin—pancreatic cancer	0.00063	0.00166	CcSEcCtD
Amifostine—ENPP1—Disease—HES1—pancreatic cancer	0.000624	0.00201	CbGpPWpGaD
Amifostine—Discomfort—Epirubicin—pancreatic cancer	0.000622	0.00164	CcSEcCtD
Amifostine—Malaise—Doxorubicin—pancreatic cancer	0.000617	0.00163	CcSEcCtD
Amifostine—Syncope—Doxorubicin—pancreatic cancer	0.000614	0.00162	CcSEcCtD
Amifostine—ENPP1—Metabolism—STK11—pancreatic cancer	0.000611	0.00197	CbGpPWpGaD
Amifostine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000604	0.00159	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000602	0.00159	CcSEcCtD
Amifostine—Shock—Epirubicin—pancreatic cancer	0.000594	0.00157	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—pancreatic cancer	0.000593	0.00156	CcSEcCtD
Amifostine—Dizziness—Docetaxel—pancreatic cancer	0.000592	0.00156	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—pancreatic cancer	0.000591	0.00156	CcSEcCtD
Amifostine—Tachycardia—Epirubicin—pancreatic cancer	0.000589	0.00155	CcSEcCtD
Amifostine—Chest pain—Doxorubicin—pancreatic cancer	0.000583	0.00154	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—pancreatic cancer	0.000576	0.00152	CcSEcCtD
Amifostine—Vomiting—Docetaxel—pancreatic cancer	0.000569	0.0015	CcSEcCtD
Amifostine—Rash—Docetaxel—pancreatic cancer	0.000564	0.00149	CcSEcCtD
Amifostine—Hypotension—Epirubicin—pancreatic cancer	0.000564	0.00149	CcSEcCtD
Amifostine—Dermatitis—Docetaxel—pancreatic cancer	0.000564	0.00149	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000559	0.00147	CcSEcCtD
Amifostine—Shock—Doxorubicin—pancreatic cancer	0.00055	0.00145	CcSEcCtD
Amifostine—ENPP1—Disease—TERT—pancreatic cancer	0.000547	0.00176	CbGpPWpGaD
Amifostine—Tachycardia—Doxorubicin—pancreatic cancer	0.000545	0.00144	CcSEcCtD
Amifostine—Dyspnoea—Epirubicin—pancreatic cancer	0.000538	0.00142	CcSEcCtD
Amifostine—Somnolence—Epirubicin—pancreatic cancer	0.000537	0.00142	CcSEcCtD
Amifostine—Nausea—Docetaxel—pancreatic cancer	0.000532	0.0014	CcSEcCtD
Amifostine—ENPP1—Metabolism—TYMS—pancreatic cancer	0.000526	0.0017	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIF1A—pancreatic cancer	0.000523	0.00169	CbGpPWpGaD
Amifostine—Hypotension—Doxorubicin—pancreatic cancer	0.000522	0.00138	CcSEcCtD
Amifostine—ENPP1—Disease—TSC2—pancreatic cancer	0.000522	0.00168	CbGpPWpGaD
Amifostine—ENPP1—Disease—APOE—pancreatic cancer	0.000511	0.00165	CbGpPWpGaD
Amifostine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000498	0.00131	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000497	0.00131	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—pancreatic cancer	0.000497	0.00131	CcSEcCtD
Amifostine—Urticaria—Epirubicin—pancreatic cancer	0.00048	0.00126	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—pancreatic cancer	0.000477	0.00126	CcSEcCtD
Amifostine—ENPP1—Disease—NOTCH1—pancreatic cancer	0.000471	0.00152	CbGpPWpGaD
Amifostine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00046	0.00121	CcSEcCtD
Amifostine—ENPP1—Disease—EGF—pancreatic cancer	0.000456	0.00147	CbGpPWpGaD
Amifostine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000445	0.00117	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—pancreatic cancer	0.000444	0.00117	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000442	0.00116	CcSEcCtD
Amifostine—ENPP1—Metabolism—APOE—pancreatic cancer	0.000428	0.00138	CbGpPWpGaD
Amifostine—Pruritus—Epirubicin—pancreatic cancer	0.000427	0.00113	CcSEcCtD
Amifostine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000412	0.00109	CcSEcCtD
Amifostine—ENPP1—Disease—PIK3CD—pancreatic cancer	0.000405	0.00131	CbGpPWpGaD
Amifostine—Dizziness—Epirubicin—pancreatic cancer	0.000399	0.00105	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—pancreatic cancer	0.000395	0.00104	CcSEcCtD
Amifostine—ENPP1—Metabolism—PIK3CG—pancreatic cancer	0.000386	0.00125	CbGpPWpGaD
Amifostine—Vomiting—Epirubicin—pancreatic cancer	0.000384	0.00101	CcSEcCtD
Amifostine—Rash—Epirubicin—pancreatic cancer	0.000381	0.001	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—pancreatic cancer	0.00038	0.001	CcSEcCtD
Amifostine—ENPP1—Metabolism—PPARG—pancreatic cancer	0.000373	0.0012	CbGpPWpGaD
Amifostine—Dizziness—Doxorubicin—pancreatic cancer	0.000369	0.000974	CcSEcCtD
Amifostine—Nausea—Epirubicin—pancreatic cancer	0.000359	0.000946	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—pancreatic cancer	0.000355	0.000937	CcSEcCtD
Amifostine—ENPP1—Disease—PIK3CB—pancreatic cancer	0.000353	0.00114	CbGpPWpGaD
Amifostine—Rash—Doxorubicin—pancreatic cancer	0.000352	0.000929	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—pancreatic cancer	0.000352	0.000928	CcSEcCtD
Amifostine—ENPP1—Disease—PTGS2—pancreatic cancer	0.00035	0.00113	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CD—pancreatic cancer	0.000339	0.00109	CbGpPWpGaD
Amifostine—Nausea—Doxorubicin—pancreatic cancer	0.000332	0.000875	CcSEcCtD
Amifostine—ENPP1—Disease—CTNNB1—pancreatic cancer	0.000313	0.00101	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTEN—pancreatic cancer	0.000305	0.000984	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CB—pancreatic cancer	0.000296	0.000954	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS2—pancreatic cancer	0.000293	0.000945	CbGpPWpGaD
Amifostine—ENPP1—Disease—SRC—pancreatic cancer	0.000283	0.000913	CbGpPWpGaD
Amifostine—ENPP1—Disease—STAT3—pancreatic cancer	0.000273	0.00088	CbGpPWpGaD
Amifostine—ENPP1—Disease—NRAS—pancreatic cancer	0.000272	0.000878	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTEN—pancreatic cancer	0.000256	0.000824	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—pancreatic cancer	0.000254	0.000818	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFB1—pancreatic cancer	0.000253	0.000816	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGFR—pancreatic cancer	0.000248	0.0008	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—pancreatic cancer	0.000234	0.000756	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CA—pancreatic cancer	0.000215	0.000694	CbGpPWpGaD
Amifostine—ENPP1—Disease—HRAS—pancreatic cancer	0.000199	0.000643	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CA—pancreatic cancer	0.00018	0.000582	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—pancreatic cancer	0.000176	0.000567	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—pancreatic cancer	0.000147	0.000475	CbGpPWpGaD
